Are There Any Clinical Trials Involving Nanotechnology?
Several clinical trials are currently investigating the use of nanotechnology for Alzheimer's disease. These trials aim to evaluate the safety and efficacy of various nanomedicine approaches, including nanoparticle-based drug delivery systems and diagnostic tools. Preliminary results are promising, showing that nanotechnology can improve drug biodistribution and target specificity, thereby enhancing the overall treatment outcomes.
